The (likely) New 2010 CDC STD Treatment Guidelines Guideline Development Process. Overview
|
|
- Bathsheba Cunningham
- 6 years ago
- Views:
Transcription
1 The (likely) New 2010 CDC STD Treatment Guidelines Deborah Cohan, MD, MPH University of California, San Francisco San Francisco General Hospital I have no financial conflicts of interest to disclose. Overview Screening recommendations Chlamydia Gonorrhea Pelvic Inflammatory Disease Mycoplasma genitalium Syphilis Herpes Simplex Virus Trichomonas Bacterial vaginosis Guideline Development Process Based on 4 outcomes Microbiologic cure Clinical cure Prevention of sequelae Prevention of Transmission Alphabetized unless prioritized Expert Panel 2009 Final GL available Fall 2010? Winter? **Final document may differ from my slides** 1
2 2010 Guidelines: Prevention Pregnancy: Emergency contraception: Plan B and OCP HIV: Male circumcision as prevention Post-exposure prophylaxis (PEP) Sexual assault section Pre-Exposure Prophylaxis (PrEP) On-going research 2010 Guidelines: Screening Sexual history with 5 P s Partners, Pregnancy Prevention, Protection from STDs, Practices, Past hx of STDs Added question about partner s concurrent partners Special populations: Pregnant women: no screening for BV, trich or HSV-2 serology Adolescents: confidentiality section expanded WSW: BV discussed but screening not recommended Correctional settings: added section on women Informing patients which STDs they are (and are NOT) getting tested for Case 1. I m here for my pap. A 20 year old female presents to your gynecology clinic saying, I m here for my pap. She has been sexually active for 4 years. She has had 1 male partner for the past 3 months and 5 lifetime partners. What screening do you (and CDC) recommend? Pap smear Gonorrhea Chlamydia HIV 1. Pap smear 2. GC, CT 3. GC, CT, HIV 4. All of the above 1% 33% 43% 23% Pap smear GC, CT GC, CT, HIV All of the abo... 2
3 STD Screening Pregnant HIV Syphilis HBsAg CT GC (if <25 or risk factors) Pap (if 21+ yo and sexually active x 3+ yr) HCV (if risk factors) Adolescents/< 25 yr old HIV (if sexually active/idu) CT and GC (annual) (<24 for USPSTF) Pap (21 yo and sexually active x 3yrs) Other STDs (if risk factors) Case 1 continued Your lab conducts NAAT testing for CT and GC. What type of specimen do you send on this woman? What type of specimen do you send on this woman? CT and GC NAAT: Specimen Types 1. Endocervical swab 2. First-void urine (aka dirty catch ) 3. Vaginal swab (clinician or patientcollected) 4. Liquid-based cytology specimen 66% 19% 9% 5% Vaginal swabs Self-collection associated with 96-98% sensitivity (equivalent to provider-collected) Sensitivity equivalent or better vs. cervical swabs and first-void urine Cervical swab=ok if doing a speculum anyway Liquid cytology media=ok Some concern about liquid media inhibiting amplification, screening low-risk populations Endocervical s... First-void uri... Vaginal swab (... Liquid-based c... Schacter STD 2005; Chernesky STD 2005; APHL/CDC Expert Consultation Meeting Summary Report
4 Case 1 continued Your patient s CT screen was positive. How do you manage this patient? Recommended Regimens: Azithromycin 1gm PO x 1 (directly observed) Amoxicillin 500mg PO TID x 7d (pregnancy) Doxycycline 100mg PO BID x 7d (not in pregnancy) Alternative Regimens: Ofloxacin 300mg BID or Levofloxacin 500mg PO daily x 7d (not in pregnancy) Erythromycin base 500mg PO QID x7d (pregnancy) Chlamydia Management: Not just a dose of antibiotics Treat all partners! Expedited Partner Therapy (to be emphasized in 2010) Currently illegal in 8 states (AK, FL, KY, MI, OH, OK, SC, WV) Inform Health Department (SF: ) Test of cure Only if pregnant, non-compliant, persistent symptoms after Rx, suspect early reinfection after Rx At least 3 wks after treatment Re-testing (not a test of cure) 3 months for all men/women with + CT (to be emphasized in 2010) Gonorrhea (Likely) 2010 Treatment Recommendations Recommended: Ceftriaxone 250mg IM x 1 plus Azithro 1 gm PO x 1 Alternative: Cefixime 400mg PO x 1 plus Azithro 1 gm PO x 1 Alternative if Cephalosporin allergy: Azithromycin 2 gm PO x 1? Pharyngeal: Ceftriaxone 250mg IM x 1 plus Azithro 1 gm PO x 1 Treat partners! Inform Health Department Test of cure Same indications as CT Re-testing in 3 months Pelvic Inflammatory Disease Diagnosis: no change in criteria CMT or adnexal tenderness or uterine tenderness Treatment: No change anticipated (14 day regimens) Azithromycin mentioned but not recommended OUT Ofloxacin* 400mg BID or Levoflox* 500mg QD with/without Metronidazole 500mg BID IN Ceftriaxone 250mg IM x1 (or other 3 rd gen Ceph) PLUS Doxycycline 100 mg PO BID with/without Metronidazole Cefoxitin 2g IV Q6hr plus Doxycycline 100mg PO/IV Q12hr Clindamycin 900 mg IV Q8 hr PLUS Gentamicin 2 mg/kg IV, then 1.5 mg/kg Q8 hr Ampicillin/Sulbactam 3g IV Q6 hr PLUS Doxycycline 100 mg PO/IV Q12 hr * FQ only if Cephalosporin contraindicated, low risk of GC, and good follow-up 4
5 Mycoplasma genitalium New section in 2010 guidelines Associated with urethritis, endometritis, PID Associated with poor reproductive health outcomes? No FDA-approved screening test Treatment unclear Azithromycin ~85% effective for male NGU Case 2. The lab memo You got a memo from your lab last month that the syphilis assay has changed. 28 yr old G1P0 at 8 weeks initiating prenatal care at your clinic. Your patient s routine prenatal lab results: EIA positive, RPR negative Why did the lab change protocols? What do these results mean? Syphilis Screening Traditional protocol Quantitative, non-specific, non-treponemal assay (RPR, VDRL) Confirmatory qualitative treponemal test (TPPA) New protocol New treponemal tests EIA/CLIA Non-treponemal test (RPR, VDRL) 2 nd treponemal test (TPPA) if EIA+/RPR- Advantages Cheaper, automated, no pipetting, no prozone effect Disadvantages Will confuse us! Not useful if prior treated syphilis or for neonatal eval Unclear significance of EIA+/RPR- (especially HIV+) Early syphilis? False positive EIA? Old untreated or treated? Primary and Secondary Syphilis 5
6 Syphilis - Treatment Genital Herpes Simplex Virus (HSV) Primary Secondary Early Latent Late Latent (>1 yr) Latent Unknown Duration Tertiary Neurosyphilis Treatment Benzathine PCN G 2.4 million Units IM Benzathine PCN G 2.4 million Units IM qweek x 3 weeks Aqueous Crystalline PCN G mill units/day IV x days PCN Allergic Doxycycline 100mg BID x2wks Tetracycline 500mg QID x2wks (Except pregnancy) Doxycycline 100mg BID x4wks Tetracycline 500mg QID x4wks (Except pregnancy) Desensitize and treat with PCN HSV is a recurrent, incurable infection. Very common (seroprevalence 5-30%+) Most people with genital HSV go undiagnosed. Both HSV-1/HSV-2 can cause genital herpes. Transmission with/without symptoms. Asymptomatic shedding more common in 1 st 2 yrs (5-10% of days vs. 2% of days) Discordant partners: 12% transmission/year 17% male to female vs. 4% female to male Genital Herpes Testing Indications for HSV-2 serology: HIV-infected, multiple partners, (MSM at risk for HIV) Comprehensive STD evaluation Other potential indications for HSV-2 serology: Recurrent/atypical symptoms with negative culture Patients with a partner with genital HSV Clinical diagnosis without lab confirmation Universal screening: NOT recommended False negative serologic test Primary infection (2 weeks 3 month for antibody production) 6
7 Genital HSV Treatment Primary: Acyclovir (ACV) 400mg TID x 7d Valacylovir (V-ACV) 1gm BID x 7d Famciclovir (FAM) 250mg TID x 7d Recurrent: ACV 400mg TID x 5d (HIV: 7-10d) ACV 800mg BID x 5d or 800mg TID x 2d V-ACV 500mg BID x 3-5d V-ACV 1gm qday x 5d (HIV: 1gm BID x 5-10d) FAM 125mg BID x5d (HIV: 500mg po BID x 5-10d) FAM 500mg x1, then 250mg BID x2d (new in 2010) FAM 1000mg po qday x 1d Suppression: ACV 400mg BID (pregnancy: 400mg TID; HIV: mg BID-TID) V-ACV 500mg po QD or 1gm po QD (HIV: 500mg po BID) FAM 250mg po BID (HIV: 500mg po BID) FAM less effective at suppressing viral shedding Impact of suppression in late pregnancy on risk of neonatal HSV? Trichomoniasis Screening Screening indications: HIV+ Consider if at risk : new/multiple sex partners, Hx STD, inconsistent condoms, sex work, IDU New assays: Rapid antigen test (OSOM; Genzyme) sens/spec vs. wet mount APTIMA TMA Trichomonas Vaginalis Analyte Specific Reagent (ASR; Gen-Probe) NAAT Can use same specimen as for APTIMA Combo 2 (for CT/GC) Other testing situations: Suspect trich but wet mount negative culture or newer assays Pap with trich confirm if low risk Trichomoniasis Treatment Recommended: Metronidazole 2gm po x 1 (pregnancy) Tinidazole 2gm po x 1 (no longer just alternative in 2010) Better GI tolerability Effective against Metronidazole-resistant trich Alternative: Metronidazole 500mg PO BID x 7d Metronidazole safe at all gestational ages Treatment failures: Metronidazole 500mg po BID x 7d or Tinidazole 2gm po x 1 If repeat failure: Metronidazole or Tinidazole 2gm po x 5d Susceptibility testing at CDC ( ) Treat partner and screen for other STIs Consider retesting in 3 months 7
8 Bacterial Vaginosis Prevention: condoms and no douching Screening NO longer recommended: Asx c high-risk pregnant women Pre-surgical Avoid expensive testing (PCR, culture) Treatment: Symptomatic BV emphasized No evidence yet for probiotics Metronidazole 2gm deleted Clindamycin cream may be less effective BV: Treatment Recommended Metronidazole (MTZ) 500mg BID x 7d (pregnancy) MTZ gel 0.75% intravaginal QHS x 5d Clindamycin cream 2% intravaginal QHS x 7d (not in pregnancy, assoc with LBW) Alternatives Clindamycin 300mg BID x7d (pregnancy) Clindamycin ovules 100mg intravaginal QHS x3d Metronidazole 250mg TID x7d (pregnancy only) Tinidazole 2gm QD x 3d (new) Tinidazole 1gm QD x 5d (new) Take It Home Screen appropriately Don t forget to screen for CT/GC if <25 CT screening in pregnancy, but otherwise avoid in older women unless indicated Vaginal swab often best method for CT/GC Test of cure for CT/GC: pregnancy Retesting in 3 months (to detect reinfection) Treat partners (know your state law) Report STI treatment to Health Department Take It Home If she has one STD, screen for other STDs including HIV. Page the RID fellow (415) with any questions or consults. Available 24/7 8
9 References and Resources CDC STD Treatment Guidelines City Clinic/SF Dept of Public Health Excellent resources for patients and providers Handheld resources Johns Hopkins antibiotic guide You! Meg Autry, MD UCSF CME office Gail Bolan, MD Thank You Jeanne Marrazzo, MD Susan Philip, MD 9
Nothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationSexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationDisclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationSTI 2016: Where We Need to Go
STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually
More informationStephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os
STD Diagnosis and Treatment Ina Park, MD, MS STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Stephanie 23 year-old female presents for contraception,
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationCategories of STI Screening and Testing Routine screening Population based risk factors Targeted screening Personal behavioral risk factors Contact te
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More informationSEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5)
SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5) BACTERIAL VAGINOSIS 1 clindamycin cream 2 Cleocin Vaginal Cream 2% vaginal cream Adults: 1 applicatorful at bedtime for 7 days metronidazole
More informationSexually Transmitted Infections: New Tests, New Guidelines
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More informationALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
More informationOverview. Disclosures. Sexually Transmitted Diseases: What s New in the Guidelines and Beyond?
Sexually Transmitted Diseases: What s New in the Guidelines and Beyond? Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationKhalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014
Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES
More informationSexually Transmitted Disease Treatment Tables
Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationEmerging Issues in STDs and Resistance
Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-
More informationEdward W. Hook, III, M.D.
Challenging Cases Edward W. Hook III M.D. Professor and Director Division of Infectious Diseases University of Alabama at Birmingham And PI, Alabama/North Carolina STD PTC Edward W. Hook, III, M.D. Grant/Research
More informationClinical Cases from the STD Clinical Consultation Network
Clinical Cases from the STD Clinical Consultation Network Christine Johnston STD TCG April 24, 2017 Last Updated: uwptc@uw.edu uwptc.org 206-685-9850 STD Clinical Consultation Network (STDCCN) Developed
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures
More informationSyphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference
Sexually Transmitted Diseases Family Medicine Board Review Course March 26, 2012 Ronald H. Goldschmidt, MD Reference Centers for Disease Control and Prevention Guidelines for Treatment of Sexually Transmitted
More informationUpdate on Sexually Transmitted Infections among Persons Living with HIV
Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationSTD UPDATE 2017 FSACOFP CONVENTION
STD UPDATE 2017 FSACOFP CONVENTION L. Michael Waters, Jr, DO Adjunct Clinical Assistant Professor of Family Medicine LECOM-Bradenton Clinical Assistant Professor of Family Medicine PCOM- Georgia DISCLOSURES
More informationGenital Tract Infections in Women. Michael S. Policar, MD, MPH UCSF School of Medicine
Genital Tract Infections in Women Michael S. Policar, MD, MPH UCSF School of Medicine www.policarlectures.com Value of STI Screening and Testing Benefits Detect infection Patient treatment Partner treatment
More informationTrends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017
Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017 1 Speaker Disclosure Dr. Woo has disclosed that she has no
More informationSTI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research
Teodora Wi Geneva, 28 August 2017 STI Treatment Guidelines Teodora Wi Training Course in Sexual and Reproductive Health Research 2017 Twitter @HRPresearch 1 STI treatment guidelines Neisseria gonorrhoeae
More information4/6/17 UNPRECEDENTED HIGH. Shelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annualmore than 1.5 million
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationUpdate on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH
Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its
More informationNew Guidelines for Detection and Treatment of Sexually Transmitted Infections
UCSF Controversies in Women s health December 8, 2016 San Francisco, CA New Guidelines for Detection and Treatment of Sexually Transmitted Infections Disclosure I am a litigation consultant to a law firm
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More informationDrugs for UTIs and STDs. Dr.Vishaal Bhat Associate Professor MMMC Manipal
Drugs for UTIs and STDs Dr.Vishaal Bhat Associate Professor MMMC Manipal Classification of UTI s Clinical: Asymptomatic (98%) Symptomatic (1-2%) Anatomical: Lower tract dis: asymptomatic bacteriuria and
More information2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE
2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE Gale R. Burstein, MD, MPH, FAAP, FSAHM Commissioner, Erie County Department of Health, Clinical Professor of Pediatrics, SUNY at Buffalo School
More informationINTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management
INTRAUTERINE DEVICES AND INFECTIONS Tips for Evaluation and Management Objectives At the end of this presentation, the participant should be able to: 1. Diagnose infection after IUD placement 2. Provide
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationSTDs in HIV Clinical Care: New Guidelines on Treatment and Prevention
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention Palliative Care Conference Faculty Development Conference August 13, 2015 Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS
More information2/17/2017. Sexually Transmitted Diseases in Children: Is it Abuse? General Considerations. Judy Guinn, MD WI CAN Educational Series February 17, 2017
Sexually Transmitted Diseases in Children: Is it Abuse? Judy Guinn, MD WI CAN Educational Series February 17, 2017 Disclosure Information for: Judy Guinn, MD Sexually Transmitted Diseases in Children:
More informationS403- Update on STIs for the Generalists
S403- Update on STIs for the Generalists Mobeen H. Rathore, MD Professor and Director University of Florida Center for HIV/AIDS Research Education and Service (UF CARES) Chief, Pediatric Infectious Diseases
More informationAlberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2008
Alberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2008 General for STI Given the current rise in all STI in Alberta, it is appropriate to assess for risk
More informationDisclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None
Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California
More informationSTIs in Primary Care. Dr Eleanor Draeger 19 th January 2016
STIs in Primary Care Dr Eleanor Draeger 19 th January 2016 Poli=cs! 2012! Health and Social Care act! Sexual Health commissioning moved to local authority! 2015! 200 million cuts to public health! 40%
More informationServices for GLBTQ Youth
Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual
More informationWhat Bugs You? A Sexually Transmitted Infection Review
What Bugs You? A Sexually Transmitted Infection Review KATIE DESIMONE, PHARM.D. Disclosures I have no financial affiliations with any of the products or therapies discussed in this presentation Objectives
More informationSexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System
Sexually Transmitted Infections in the Adolescent Population Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System STI in the Adolescent High school students nationwide, 34.2% were
More informationHOT OFF THE PRESS! R.
STI Update 2016: New CDC Treatment Guidelines Focus on the Female HOT OFF THE PRESS! R. Mimi Secor, DNP, FNP-BC, FAANP Onset, Massachusetts Mimi Secor, DNP, FNP-BC, FAANP Nurse Practitioner for 40 years
More informationCLINICAL MANAGEMENT OF STDS
CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual
More informationDisclosure Information Julie Stoltey, MD MPH
Courtesy CDC Public Health Image Library The New Yorker 2012 2016 Update on Testing, Treatment, and Gonorrhea Resistance Julie Stoltey, MD, MPH STD Control Branch-California Dept. of Public Health Assistant
More informationSEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS
SEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS Sarah Garwood MD, Assistant Professor of Pediatrics, Washington University Elizabeth Fox MD, Pediatric Resident, St Louis Children s Hospital STDS IN ADOLESCENTS
More informationSexually Transmitted Diseases
Table of content Sexually Transmitted Diseases Judith A. Lightfoot DO, FACOI Update on the prevalence of STD s in the US Which populations are greatly affected? Should we be alarmed? How does this affect
More informationTO DECREASE THE CHANCE OF GETTING
POST ASSAULT MEDICATIONS Terri Stewart RN Naomi Sugar MD TO DECREASE THE CHANCE OF GETTING Pregnant STDs Chlamydia Gonorrhea Trichomonas Hep B HIV EMERGENCY CONTRACEPTION Plan B Levonorgestrel PLAN B Plan
More information7/24/2012. Estimates of Sexually Transmitted Infections in the U.S.
Faculty Trich and Treat Jane R. Schwebke, MD Professor of Medicine Infectious Diseases University of Alabama at Birmingham Satellite Conference and Live Webcast Wednesday, July 25, 2012 10:00 a.m. - 12:00
More informationSexually Transmitted Diseases:
Sexually Transmitted Diseases: Diagnosis and Management Department of Internal Medicine, Division of Infectious Diseases University of New Mexico A 21 year old woman comes to your clinic asking to be checked
More informationThe Great Imitator Revealed: Syphilis
The Great Imitator Revealed: Syphilis Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles David Geffen School of Medicine Los Angeles, California Learning
More informationDidactic Series. STD Screening & Management: Syphilis. Christian B. Ramers, MD, MPH
Didactic Series STD Screening & Management: Syphilis Christian B. Ramers, MD, MPH Assistant Medical Director Family Health Centers of San Diego Ciaccio Memorial Clinic 3/26/15 ACCREDITATION STATEMENT:
More informationShelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annual more than 1.5 million
More information8/5/2014. STIs in the United States: What s Happening. Overview. Gail Bolan, M.D. 13% 5% 7% 11% 12% 33% 19%
STIs in the United States: What s Happening Chlamydia Percentage of Reported Cases Among Women by Source of Report, 213 Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS,
More informationRETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance
RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance Ina Park, MD, MS University of California San Francisco California Prevention Training Center DISCLOSURE No Relevant
More informationOverview. Disclosures. Sexually Transmitted Diseases: Key Clinical Information for 2017
Sexually Transmitted Diseases: Key Clinical Information for 2017 Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public Health
More information3/28/2016. Why you should care? Dana W. Dunne, MD, FACP Associate Professor of Medicine Yale University School of Medicine New Haven, Connecticut
Sexually Transmitted Diseases (STDs) and HIV: Top Ten Highlights for Clinicians Dana W. Dunne, MD, FACP Associate Professor of Medicine Yale University School of Medicine New Haven, Connecticut FINAL:
More information- Polyurethane condoms comparable to latex. - Natural (i.e. Lamb Skin) - Pores 10x > diameter of HIV virus; 25x > diameter Hep B
DISCLOSURES CDC STI Update NONE James W. Haynes, M.D. Associate Professor, Family Medicine UT College of Medicine - Chattanooga If STI await completion of therapy and resolution of symptoms prior to resuming
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationShelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annual more than 1.5 million
More informationAdvances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol
Advances in STI diagnostics Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Rapid expansion in on-line STI testing Outstripping NHS expert advice Increasing
More informationBest Practices in STD Partner Management
Best Practices in STD Partner Management An Overview of Patient-Delivered Partner Therapy (PDPT) and Counseling for Partner Notification and Treatment Amber Eisenmann, MS Director of Learning Exchange
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationSTIs- REVISION. Prof A A Hoosen
STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex
More informationLABORATORY DIAGNOSIS SEXUALLY TRANSMITTED DISEASES
LABORATORY DIAGNOSIS SEXUALLY TRANSMITTED DISEASES LABORATORY MEDICINE COURSE 2004 CLINICAL MICROBIOLOGY SERVICE STD EPIDEMIC- USA TIP OF THE ICEBERG INCIDENCE DISCHARGE Chlamydia - 4 million Gonorrhea
More informationClinical Education Initiative ADOLESCENTS AND STDS: CASE STUDIES. Tara Babu, MD
Clinical Education Initiative Support@ceitraining.org ADOLESCENTS AND STDS: CASE STUDIES Tara Babu, MD 2/16/2017 Adolescents and STDs: Case Studies [video transcript] 00:00:08 - Hello, my name is Tia Babu
More informationCDC Laboratory Update
CDC Laboratory Update Chlamydia and Gonorrhea Laboratory Guidelines Overview of the APHL / CDC STD Steering Committee Laboratory Recommendations for the Detection of Chlamydia trachomatis, Neisseria gonorrhoeae
More informationSelassie AW (DBBE) 1. Overview 12 million incident cases per year $10 billion economic impact More than 25 organisms.
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 12 Sexually Transmitted Diseases Learning Objectives 1. Review the epidemiology of sexually Transmitted Diseases 2. Assess the personal
More informationSTIs: Practical Aspects of Management
STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS
More informationClinical Prevention Behavioral Prevention Counseling
38 th National Conference on Pediatric Health Care March 16-19, 2017 Disclosures Sexually Transmitted Infections: Update on Screening, Testing and Treatment Guidelines Brenda Cassidy, DNP, RN, CPNP Assistant
More informationPodcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43
Podcast Transcript Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 NCTCFP: Welcome to this podcast sponsored by the National
More informationSex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046) Kenneth A. Katz, MD, MSc, MSCE Dermatologist, Kaiser Permanente, San Francisco, CA AAD Annual Meeting, Orlando, FL March 4, 2017
More informationPublic/Private Partnerships: Intervening in the Spread of Syphilis
Public/Private Partnerships: Intervening in the Spread of Diana Torres-Burgos MD, MPH Gerard Castaneda, BSN Alana Thomas, BS STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline overview Stages
More informationVaginitis and STIs Causes, Work-up, Treatment
Vaginitis and STIs Causes, Work-up, Treatment E.J. Mayeaux, Jr., M.D., FAAFP Professor of Family Medicine Professor of Obstetrics/Gynecology Louisiana State University Health Sciences Center Shreveport,
More information5/12/11. STI s in Adolescents: Exposing the Hidden Epidemic. Why the hidden epidemic?
STI s in Adolescents: Exposing the Hidden Epidemic Youth and Sexually Transmitted Infections 2011 Mary-Ann Shafer, MD Professor & Vice Chair Department of Pediatrics Division of Adolescent Medicine University
More informationScreening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016
Screening & Treating Chlamydia in Primary Care Wednesday, September 21, 2016 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary
More informationSexually Transmitted Infections Angela Farrell MD Dept of Family Medicine University of Iowa
Sexually Transmitted Infections Angela Farrell MD Dept of Family Medicine University of Iowa Objectives Review taking a sexual history Discuss screening, diagnosis, and management of chlamydia, gonorrhea,
More informationGonococcal Infection- Treatment Consideration
Gonococcal Infection- Treatment Consideration First generation cephalasporin allergy in 5-10% of patients with PCN allergy Contraindicated in those with a severe reaction Anaphylaxis Stevens Johnson syndrome
More informationSTD Prevention Among Youth
STD Prevention Among Youth Jody Pierce Glover New Beginnings Emer S. Smith, MPH Maine Center for Disease Control & Prevention In Today s Talk... Maine Learning Results: Education Content Areas Health Behaviors
More information2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing
2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing Joan M. Chow, MPH, DrPH Surveillance, Epidemiology, Assessment & Evaluation Section Sexually Transmitted Disease Control Branch Division
More informationChallenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A
Challenging STD Cases Chris Davis, PA-C University of Utah Clinic 1A Case #1 28 year old HIV + MSM presents for first HIV visit with lesion on glans of penis CD4 count of 3 and viral load of 610,000 Multiple
More informationHot Topics in STIs. Melanie Deal, MS, FNP-BC University of California Berkeley-Tang Center California Prevention Training Center
Hot Topics in STIs Melanie Deal, MS, FNP-BC University of California Berkeley-Tang Center California Prevention Training Center Ina Park, MD, MS California Prevention Training Center STD Control Branch
More informationComplex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes ReachMD Page 1 of 5
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationIndex. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.
Infect Dis Clin N Am 19 (2005) 563 568 Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of,
More informationManagement that provides continuity of care for women
Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred
More informationRefocussing on STI management to impact HIV prevention
Refocussing on STI management to impact HIV prevention Koleka Mlisana Head: Medical Microbiology (UKZN & NHLS) 14 June 2017: SA AIDS Conference NSP 2017 2022 Objectives Goal 1:Accelerate preventioninorder
More informationDermatologist Venereologist MD, PhD
Vassiliki Mousatou Dermatologist Venereologist MD, PhD Genital warts Genital herpes Syphilis Gonococcal and no gonococcal urethritis HIV Hepatitis B and C Also: Lymphogranuloma venereum and Granuloma
More informationSay Ahhh!, STDs in Maine. Emer Smith, Maine CDC,
Say Ahhh!, STDs in Maine Emer Smith, Maine CDC, emer.smith@maine.gov Say AHHH! : STDs in Maine Emer S. Smith, MPH Maine Center for Disease Control & Prevention HIV, STD, & Viral Hepatitis Program April
More informationChlamydia Curriculum. Chlamydia. Chlamydia trachomatis
Chlamydia Chlamydia trachomatis 1 Learning Objectives Upon completion of this content, the learner will be able to: 1. Describe the epidemiology of chlamydial infection in the U.S. 2. Describe the pathogenesis
More informationSexually Transmi/ed Diseases
Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human
More informationLove Bugs and Drugs Managing Sexually Transmitted Infections in Teens. Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine
Love Bugs and Drugs Managing Sexually Transmitted Infections in Teens Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine 37 th Annual Sanford Black Hills Pediatric Symposium June 26,
More information